Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Rev Assoc Med Bras (1992) ; 66(7): 1002-1008, 2020. tab, graf
Article in English | SES-SP, LILACS | ID: biblio-1136306

ABSTRACT

SUMMARY The increase in bilirubin levels in newborns can cause toxic effects on the auditory system, which can lead to hearing loss. This review aimed to verify the impact of hyperbilirubinemia in the hearing of newborns, relating audiological findings to serum levels of bilirubin. A literature review was conducted during October 2017, using the terms "hyperbilirubinemia", "jaundice", "infant", "newborn" and "hearing loss", on databases CAPES journals, MEDLINE and BIREME (SciELO, BBO). 827 studies were identified and 59 were selected for full-text reading, resulting in the selection of seven articles that met the inclusion criteria and were considered relevant to the sample of this study. All the reviewed studies performed brainstem auditory evoked potential as the main test for audiological evaluation. Changes in the audiological findings of neonates with hyperbilirubinemia were observed in all studies. There was no consensus on the serum bilirubin levels that may cause auditory changes; however, the relationship between hearing disorders and blood levels of bilirubin was positive. We identify the need to establish reference values for bilirubin levels considered critical for the occurrence of hearing disorders as well as the audiological follow-up of neonates with hyperbilirubinemia.


RESUMO O aumento nos níveis de bilirrubina no neonato pode provocar efeitos tóxicos no sistema auditivo, podendo levar à perda auditiva. O objetivo desta revisão foi verificar o impacto da hiperbilirrubinemia na audição de recém-nascidos, relacionando os achados audiológicos aos níveis séricos de bilirrubina. Realizou-se uma revisão sistemática de literatura durante o mês de outubro de 2017, utilizando-se os termos hyperbilirubinemia, jaundice, infant, newborn e hearing loss, nas bases de dados periódicos Capes, Medline e Bireme (SciELO, BBO). Foram identificados 827 estudos, dentre os quais 59 foram selecionados para leitura do texto na íntegra, resultando na seleção de sete artigos que atendiam aos critérios de inclusão e foram considerados relevantes para a amostra deste trabalho. Em todas as pesquisas revisadas, o potencial evocado auditivo de tronco encefálico foi o principal exame audiológico realizado. Em todos os estudos foram observadas alterações nos resultados audiológicos de neonatos com hiperbilirrubinemia. Não houve consenso quanto aos níveis séricos de bilirrubina que podem causar alterações auditivas, porém, a relação entre as alterações audiológicas e os níveis sanguíneos de bilirrubina foi positiva. Percebeu-se a necessidade de estabelecer valores de referência para os níveis de bilirrubina considerados críticos para a ocorrência de alterações audiológicas, assim como de acompanhamento audiológico dos neonatos com hiperbilirrubinemia.


Subject(s)
Humans , Infant, Newborn , Evoked Potentials, Auditory, Brain Stem , Hearing Loss/complications , Audiometry , Bilirubin , Hyperbilirubinemia/complications
2.
Rev. méd. Minas Gerais ; 22(supl.5): S40-S42, 2012.
Article in Portuguese | LILACS | ID: biblio-969352

ABSTRACT

O diabetes mellitus gestacional (DMG) está associado a um risco aumentado de complicações fetais, neonatais e no desenvolvimento a longo prazo. As taxas de aborto espontâneo, natimorto, mal formações congênitas e morbidade e mortalidade perinatal são maiores em filhos de mães diabéticas. As principais complicações neonatais são: macrossomia, hipoglicemia neonatal, deficiência de ferro, alterações da função cardiorrespiratória, hiperbilirrubinemia, anormalidades neurológicas, hipocalcemia, hipomagnesemia e policitemia. A macrossomia predispõe a lesões do parto, especialmente distócia de ombro, maior risco de lesão do plexo braquial, fraturas de clavícula ou do úmero, asfixia perinatal, e, menos frequentemente, hemorragia subdural e paralisia facial. O controle glicêmico rigoroso pré-concepção e durante a gestação associa-se com menor morbimortalidade perinatal. Assim, o controle do DMG representa tarefa de fundamental importância para impedir sequelas em neonatais. (AU)


The gestational diabetes mellitus (GDM) is associated with an increased risk of fetal, neonatal, and possibly long-term complications. The rates of spontaneous abortion, stillbirth, congenital malformations, and perinatal morbidity and mortality are higher in infants of a diabetic mother than in pregnancies with normal glycemic control. The main neonatal complications are: macrosomia, neonatal hypoglycemia, iron deficiency, changes in cardiac and respiratory function, hyperbilirubinemia, neurological abnormalities, hypocalcemia, hypomagnesemia and polycythemia. Macrosomia predisposes to birth injury, especially shoulder dystocia, increased risk of brachial plexus injury, clavicular or humeral fractures, perinatal asphyxia, and, less often, subdural hemorrhage and facial palsy. Strict glycemic control preconception and during pregnancy is associated with lower perinatal morbidity and mortality. Thus, GDM control is of paramount importance to prevent neonatal harm. (AU)


Subject(s)
Humans , Female , Pregnancy , Infant, Newborn , Pregnancy Complications , Fetal Macrosomia/complications , Diabetes, Gestational , Polycythemia/complications , /complications , Blood Glucose , Brachial Plexus/injuries , Clavicle/injuries , Congenital Hyperinsulinism/complications , Dystocia , Facial Paralysis/complications , Humeral Fractures/complications , Hyperbilirubinemia/complications , Nervous System Malformations/complications
3.
J. bras. med ; 99(1): 24-32, mar.-maio 2011. ilus, tab, graf
Article in Portuguese | LILACS | ID: lil-597342

ABSTRACT

Para descobrir quais as doenças que mais comumente cursam com a icterícia em pacientes internados no Hospital Universitário Antônio Pedro (HUAP) e correlacioná-las com marcadores bioquímicos foram utilizados dados extraídos de prontuários de pacientes internados durante os anos de 2005 a 2007. 0s dados foram analisados usando métodos estatísticos como qui-quadrado e teste Z. Utilizamos a análise das dosagens de aspartato-aminotrans ferase (AST), alanina-aminotransferase (ALT), fosfatase alcalina (FA), gama-glutamiltransferase (gama-GT), bilirrubina (Bb) total e suas frações direta e indireta. Os sinais e sintomas mais comuns na amostra estudada foram: dor abdominal, vômitos e colúria, que estão presentes em cerca de 60% das queixas dos pacientes estudados. Na população entre nove e 85 anos de idade, a análise sugere que AST e ALT nos chamam atenção para uma possível lesão hepática associada aos casos de icterícia. Enquanto que FA e GGT são marcadores de colestase. A bilirrubina direta tem média mais elevada no grupo de pacientes entre nove e 85 anos e a bilirrubina indireta atinge níveis maiores no grupo com até dois meses de vida. As dosagens bioquímicas são armas muito importantes na pesquisa etiológica dos casos de icterícia.


To find out which diseases most commonly lead to jaundice in hospitalized patients in HUAP and correlate them with biochemical markers. We used data from medical records of patients hospitalized during the years 2005 to 2007. The data were analyzed using statistical methods to test and chi-square-Z. We used the analysis of the strengths of AST, ALI, FA, GGT, Bb and its fractions total direct and indirect. The most common signs and symptoms in the sample studied were abdominal pain, vomiting and choluria that are present in about 60% of complaints from patients. In the population between nine and 85 years of age, the analysis suggests that AST and ALT in calling attention to a possible liver damage linked to cases of jaundice. While FA and gamma-GT are markers of cholestasis. The direct bilirubin is highest average in the group of patients between nine and 85 years and indirect bilirubin levels higher in the group with up to two months of life. The biochemical doses are very important weapons in the etiological research of cases of jaundice.


Subject(s)
Humans , Male , Female , Liver Diseases/classification , Liver Diseases/etiology , Jaundice/complications , Jaundice/diagnosis , Jaundice/etiology , Jaundice/physiopathology , Age Distribution , Bilirubin/metabolism , Clinical Laboratory Techniques , Hyperbilirubinemia/complications , Biomarkers , Sex Distribution
4.
Journal of Korean Medical Science ; : 1427-1430, 2010.
Article in English | WPRIM | ID: wpr-112651

ABSTRACT

Hyperbilirubinemia is frequently observed in Caucasian HIV patients treated with atazanavir. UDP-glucuronosyltransferase 1A1 polymorphism, UGT1A1*28, which is associated with atazanavir-induced hyperbilirubinemia, is less common in Asians than in Caucasians. However, little is known about the incidence of atazanavir-associated hyperbilirubinemia in Asian populations. Our objective was to investigate the incidence of and tolerability of atazanavir-associated hyperbilirubinemia in Korean HIV patients. The prevalence and cumulative incidence of atazanavir-associated hyperbilirubinemia and UGT1A1*28 allele frequency was investigated in 190 Korean HIV-infected patients treated with atazanavir 400 mg per day. The UGT1A1*28 were examined by direct sequencing of DNA from peripheral whole blood. The UGT1A1*28 allele frequency was 11%. The cumulative incidence of any grade of hyperbilirubinemia was 77%, 89%, 98%, and 100%, at 3, 12, 24, and 30 months, respectively. The cumulative incidence of severe (grade 3-4) hyperbilirubinemia was 21%, 41%, 66%, and 75%, at 3, 12, 24, and 30 months, respectively. However, the point prevalence of severe hyperbilirubinemia did not increase with time and remained around 25%. Our data suggest that atazanavir-associated hyperbilirubinemia is common but transient in a population with low UGT1A1*28 allele frequency.


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Alleles , Anti-HIV Agents/adverse effects , Asian People/genetics , Follow-Up Studies , Gene Frequency , Glucuronosyltransferase/blood , HIV Infections/complications , Hyperbilirubinemia/complications , Incidence , Oligopeptides/adverse effects , Promoter Regions, Genetic , Pyridines/adverse effects , Republic of Korea
5.
Rev. otorrinolaringol. cir. cabeza cuello ; 69(3): 271-280, dic. 2009. tab, graf
Article in Spanish | LILACS | ID: lil-559569

ABSTRACT

Los hallazgos clínicos que definen una neuropatía/des sincronía (NA/DA) son la integridad de las células ciliadas evidenciado, mediante la presencia de emisiones otoacústicas evocadas (EOAe) y/o la presencia de potenciales microfónicos cocleares (PMIC), junto con la ausencia de actividad neural evocada a nivel del VIII par craneano (potencial de acción compuesto) y tronco cerebral (potencial evocado auditivo de tronco (PEAT)). Las condiciones clínicas relacionadas con una NA/DA incluyen a la hiperbilirrubinemia, enfermedades neurovegetativas (ejemplo ataxia de Friedreich), síndrome de Charcot-Marie-Tooth así como otras neuropatías sensoriomotoras, desórdenes mitocondriales y neuropatías isquémica-hipóxicas como resultados de asfixia. El desarrollo de las habilidades auditivas y comunicacionales pueden estar comprometidas en forma importante en los niños con aparición prelingual de una NA/DA, mayor es aún este compromiso al no existir un perfil pronóstico preestablecido del desarrollo y resultados en el tratamiento de este desorden. En la actualidad existen múltiples estudios en donde se ha observado que hasta 50 por ciento de los pacientes con NA/DA presentan algún grado de beneficio al usar audífonos por lo que se sugiere que sistemas de amplificación como los audífonos o incluso implante coclear deberían ser el primer paso en el proceso de (re)habilitación.


The clinical findings that define an auditory neuropathy/dyssynchrony (AN/Dys) are the integrity of the outer hair cells demonstrated by the presence of evoked otoacoustics emissions (OAEe) and/or the presence of cochlear microphonic potential (CMP) along with the absence of neural activity evoked at level of VIII nerve (action potential compound) and brainstem (Auditory Brainstem Response, ABR). The clinical conditions related to an AN they include hiperbilirrubinemia, neurodegenerative diseases (eg ataxia of Friedreich), Charcot-Marie-Tooth syndrome as well as other sensoriomotor neuropathies, mitocondrial disorders and hypoxic neuropathy as perinatal asphyxia. The development of the auditory and communicational abilities can be compromise in children with prelingual onset of an AN/Dys, the development and results of treatment of this disorder is still this commitment when not existing a profile prognosis. At the present time multiple studies have been observed that until a 50 percent of the patients with AN present some degree of benefit using hearing aids, reason why it suggests amplification systems as the hearing aids or even cochlear implant would have to be the first step in the process of (re) habilitation of these patients.


Subject(s)
Humans , Auditory Diseases, Central/diagnosis , Auditory Diseases, Central/etiology , Auditory Diseases, Central/therapy , Audiometry, Evoked Response , Otoacoustic Emissions, Spontaneous/physiology , Auditory Diseases, Central/epidemiology , Hyperbilirubinemia/complications , Hypoxia-Ischemia, Brain/complications , Hereditary Sensory and Motor Neuropathy/complications , Evoked Potentials, Auditory, Brain Stem/physiology , Prevalence
6.
Indian J Pediatr ; 2006 Dec; 73(12): 1085-8
Article in English | IMSEAR | ID: sea-82725

ABSTRACT

OBJECTIVE: The main objective of this study was to describe frequency of risk factors in newborns who present different types of apnea in polysomnographic (PSG) recordings in neonatal care units. METHODS: The study was carried out in neonatal care units of a perinatal tertiary level institution in Mexico City between August 2002 and August 2003. Infants were selected from among 223 infants if they presented any type of apnea event in sleep PSG recordings. RESULTS: Nearly 25% of patients from a neonatal care unit presented apnea events. Infants with apnea showed lower values of age, weight, and cephalic perimeter at birth than infants without apnea, but did not show more neurologic risk factors. Central apnea events were more frequent in infants with preterm birth (birthweight < 1,500 g), obstructive apnea events were observed in infants with hyperbilirubinemia and gastro-esophageal reflux, while mixed events were seen in infants with sepsis, and hyperbilirubinemia. Sleep PSG recordings detected that 36% of infants with apnea have no previous clinic suspicion of the problem. CONCLUSION: Central events of apnea were found more frequent in infants with preterm birth, obstructive events in newborns with hyperbilirubinemia and gastroesophagic reflux, while infants mixed apnea had more frequent hyperbilirubinemia and sepsis.


Subject(s)
Apnea/complications , Gastroesophageal Reflux/complications , Humans , Hyperbilirubinemia/complications , Incidence , Infant, Newborn , Intensive Care Units, Neonatal/statistics & numerical data , Mexico/epidemiology , Polysomnography , Premature Birth , Sepsis/complications , Sleep Apnea, Central/complications , Sleep Apnea, Obstructive/complications
8.
Rev. cuba. endocrinol ; 11(2): 121-34, mayo-ago. 2000. tab
Article in Spanish | LILACS, CUMED | ID: lil-295687

ABSTRACT

Se hizo una revisión para valorar los criterios actuales en relación con la repercusión del embarazo en las mujeres diabéticas con nefropatía diabética. En los últimos años hemos asistido a una disminución significativa de la mortalidad en estas pacientes. Cuando se logra un control metabólico óptimo y no existen complicaciones vasculares el índice de supervivencia es idéntico al de la embarazada no diabética, aunque no siempre se logra el control aspirado antes y durante el embarazo y, con frecuencia, coexisten en ellas complicaciones angiopáticas, lo que influye en la morbilidad y la mortalidad perinatal. El riesgo antes señalado se eleva aún más en las diabéticas con nefropatía. Muchos opinan que el embarazo no aumenta el riesgo subsecuente de nefropatía ni la aceleración de su progresión. Otros sin embargo, piensan que el embarazo puede elevar la morbilidad y la mortalidad perinatal. Se ha comprobado que el riesgo de preeclampsia, prematuridad y cesáreas es significativamente mayor en las diabéticas embarazadas con nefropatía. Otras complicaciones como: hipoglucemia, hiperbilirrubinemia, síndrome de distrés respiratorio, hipocalcemia y policitemia continúan presentando un índice alto en este grupo de mujeres. Un problema aún no resuelto del todo se relaciona con la incidencia elevada de malformaciones congénitas en esta mujeres. El control estricto del metabolismo y de la hipertensión arterial y la prevención del sufrimiento fetal son acciones que pueden contribuir a la reducción de la mortalidad de los hijos de madres diabéticas. El desarrollo de los cuidados intensivos de estos neonatos es otro proceder a tener en consideración(AU)


A review was made to evaluate the current criteria in connection with the repercussion of pregnancy on diabetic women with diabetic nephropathies. During the last years a significant reduction of mortality has been observed in these patients. When an optimum metabolic control is attained and there are no vascular complications the survival index is identical to that of the non-diabetic women, eventhough the desired control is not always obtained before and during pregnancy and angiopathic complications frequently coexist in them, which influences on perinatal morbidity and mortality. The above risk is even higher among diabetic patients with nephropathy. Many consider that pregnancy increases neither the subsequent risk of nephropathy nor the acceleration of its progression. However, others think that pregnancy may rise the perinatal morbi-mortality. It has been proved that the risk of preeclampsia, prematurity and cesarean sections is significantly higher in diabetic pregnant women with nephropathy. There is still a high index of complications such as hypoglucaemia, hyperbilirubinaemia, respiratory distress syndrome, hypocalcaemia and polycythaemia in this group of women. A problem that has not been solved yet is that related to the high incidence of congenital malformations in these women. The strict control of metabolism and arterial hypertension and the fetal suffering may contribute to the reduction of mortality of the children of diabetic mothers. The development of intensive care of these newborn infants is another procedure that should be taken into consideration(AU)


Subject(s)
Humans , Infant, Newborn , Pregnancy in Diabetics/diagnosis , Indicators of Morbidity and Mortality , Diabetic Nephropathies/complications , Fetal Distress , Survivorship , Hyperbilirubinemia/complications
9.
Rev. Col. Bras. Cir ; 26(5): 269-73, set.-out. 1999. ilus, tab
Article in Portuguese | LILACS | ID: lil-275083

ABSTRACT

A cicatrização da pele e do intestino podem ser influenciadas pela elevação da bilirrubina. Com o objetivo de avaliar o possível efeito da icterícia obstrutiva sobre a sutura da pele e de anastomose jejunal, foram estudados 32 ratos, divididos em quatro grupos (n=8) e acompanhados em períodos pós-operatórios de sete e 14 dias. Todos os animais foram submetidos a laparotomia e anastomose jejunal. Os grupos 1 e 2 serviam como controle dos grupos 3 e 4, os quais foram submetidos a ligadura do ducto biliopancreático. Os animais dos grupos 1 e 2 mantiveram o mesmo peso corporal durante todo o período de acompanhamento, enquanto os ictéricos apresentaram uma queda ponderal significativa após sete dias (p<0,05). Não houve diferença na resistência da sutura de pele entre os ratos ictéricos e não-ictéricos. Após duas semanas, a icterícia reduziu a resistência anastomótica jejunal (p<0,01). O exame histológico revelou menor grau de desenvolvimento da fibrose cicatricial nas anastomoses dos ratos ictéricos. Conclui-se que a icterícia obstrutiva pode atuar negativamente sobre a cicatrização tissular. Deve-se ressaltar a importância dos fatores associados à icterícia na gênese desse efeito


Subject(s)
Animals , Rats , Cholestasis/complications , Wound Healing , Hyperbilirubinemia/complications , Anastomosis, Surgical , Jejunum/surgery , Rats, Sprague-Dawley
10.
Rev. Soc. obstet. ginecol. B.Aires ; 77(934): 302-14, nov. 1998. tab
Article in Spanish | LILACS | ID: lil-239424

ABSTRACT

La colestais intrahepática del embarazo (CG) es la segunda causa de ictericia durante la gestación, luego de la hepatitis viral. Presenta una prevalencia variable según área geográfica y se la relaciona con potencial morbimortalidad perinatal y materna. En diversas revisiones realizadas por nuestro grupo en el Servicio de Obstetricia del Hospital Materno Infantil Ramón Sardá, hemos observado un claro rol diagnóstico para el valor de fosfatasa alcalina, pero a su vez esta enzima no aumenta su valor en asociación con complicaciones perinatales. Como contrapartida, en una revisión durante 1995 pareció observarse una relación entre complicaciones perinatales e incremento en los valores de bilirrubina total. Estas obvservaciones sugieren que la fosfatasa alcalina retiene un clave rol diagnçostico para CG, pero se insinúa una asociación entre complicaciones perinatales y elevación de los valores de bilirrubina total


Subject(s)
Humans , Female , Pregnancy , Adolescent , Adult , Alkaline Phosphatase , Bile Acids and Salts , Cholestasis, Intrahepatic , Cholestasis/blood , Cholestasis/diagnosis , Hyperbilirubinemia/complications , Infant, Low Birth Weight , Pregnancy Complications , Prognosis , Argentina
12.
Pediatria (Säo Paulo) ; 19(2): 101-9, jul.-set. 1997. ilus, tab
Article in Portuguese | LILACS | ID: lil-201074

ABSTRACT

Desde o reconhecimento das possiveis sequelas da hiperbilirrubinemia no cerebro, se tem observado que alguns recém-nascidos ictericos sem doença hemolitica, mesmo com niveis considerados elevados, näo apresentam encefalopatia bilirrubinica. Objetivos: o objetivo deste estudo foi o de avaliar as possiveis sequelas auditivas e neuropsicomotoras da hiperbilirrubinemia em recém-nascidos ictericos tratados convencionalmente no período neonatal. Casuistica e metodos: foram observados prospectivamente 20 recém-nascidos de termo ictericos (11 com doença hemolitica) que necessitaram de fototerapia ou de exsanguineotransfusäo do Hospital Universitário da USP, através de exame neurológico, teste de Gesell e teste comportamental de Downs desde o periodo neonatal ate um ano de idade...


Subject(s)
Humans , Infant, Newborn , Ear Canal/injuries , Hyperbilirubinemia/complications , Jaundice/etiology , Jaundice/therapy , Neurologic Manifestations
15.
Salud pública Méx ; 37(3): 205-210, mayo-jun. 1995. tab
Article in Spanish | LILACS | ID: lil-167359

ABSTRACT

En un estudio de corte transversal se analizaron por audiometría de tonos puros entre las frecuencias de 125 a 8000 Hz, por condicionamiento operante, en 30 niños sobrevivientes de una unidad de cuidados intensivos neonatales, entre 36 y 72 meses de edad, encontrándose que tres padecían hipoacusia. Los factores de riesgo encontrados con mayor frecuencia en la muestra estudiada fueron hiperbilirrubinemia, asfixia al nacer y administración de fármacos ototóxicos. Todos los pacientes con hipoacusia tenían antecedente de parto pretérmino; además uno había sufrido hipoxia al nacimiento y otros dos hiperbilirrubinemia; los pacientes presentaron un promedio de 2.26 facotres de riesgo. Se concluye que el daño auditivo de origen perinatal es de etiología multicausal en la génesis de este tipo de hipoacusia


Thirty preschool children who survived from a neonatal intensive care unit were studied with pure tone audiometry between 125 to 8000 Hertz. Examinations were performed in a cross-sectional study at 36 to 72 postnatal months of age. Hypoacusis was found in three patients. Risk factors most frequently found in hypoacustic children were hyperbilirubinemia, hypoxia neonatorum and ototoxic exposure. All hypoacustic children had a history of preterm birth, one suffered hypoxia neonatorum, and two hyperbilirubinemia. The patients' group had an average of 2.26 risk factors. These data suggest that perinatal auditory damage occurs in the presence of additional hearing damage risk factors leading to hypoacusis.


Subject(s)
Humans , Male , Female , Infant, Newborn , Child, Preschool , Child , Asphyxia Neonatorum/complications , Infant, Premature , Intensive Care Units, Neonatal , Risk Factors , Follow-Up Studies , Hyperbilirubinemia/complications , Audiometry, Pure-Tone , Hearing Disorders/diagnosis , Hearing Disorders/etiology
17.
Pró-fono ; 4(1): 27-30, mar. 1992. graf
Article in Portuguese | LILACS | ID: lil-227986

ABSTRACT

Os autores avaliaram pela BSER 30 neonatos portadores de hiperbilirrubinemia, oriundos da Disciplina de Perinatologia. A maioria dos sujeitos foram avaliados com menos de 2 semanas de vida (21/3); houve perdominância do sexo masculino em 60 (por cento) (18/30); a hiperbilirrubinemia variou de 9,0 mg/dl, com média de 17,5 mg/dl. As patologias mais frequentes associadas foram a hipoxemia perinatal (7/30) e a administraçäo de aminoglicosídeos (7/30). Dos 30 sujeitos analisados pela BSER 40 (por cento)(12/30) apresentaram respostas normais, 13,5 (por cento) (4/30) disacusia unilateral e 46,5 (por cento) (14/30) disacusia bilateral. Dos ouvidos avaliados, ocorreram 26,5 (por cento)(16/60) com alteraçöes sensoriais, 10 (por cento) (6/60) com alteraçöes neurais e 16,5 (por cento)(10/60) com BSER sem respostas. Quanto à intensidade da deficiência auditiva, aferida pelo limiar eletrofisiológico, 53 (por cento) (32/60) dos ouvidos apresentaram disacusia severa e/ou profunda (limiar acima de 71 dB NA). Em 6 neonatos foram feitas monitorizaçäo pela BSER pré e pós exsanguíneo-transfusäo. Destes, 2 pacientes apresentaram respostas normais nas 2 situaçöes; em 4 sujeitos portadores de disacusia severa/profunda bilateral apresentaram normalizaçäo das respostas à BSER após a exsanguíneo-transfusäo


Subject(s)
Humans , Infant, Newborn , Male , Female , Audiometry, Evoked Response , Hyperbilirubinemia/complications , Aminoglycosides/adverse effects , Hyperbilirubinemia/epidemiology , Hypoxia/complications
18.
Article in English | IMSEAR | ID: sea-41146

ABSTRACT

Nine G-6-PD subjects developed acute hemolysis and severe hyperbilirubinemia (up to 61.1 mg/dl) following viral hepatitis. All except one had fever at presentation. Neutrophilic leukocytosis was a common feature. Elevation of both alanine aminotransferase (SGPT) and extremely high level of aspartate aminotransferase (SGOT) were prominent. Three developed acute renal failure. All patients survived, one after peritoneal dialysis. Recognition of the clinical picture is essential to prevent serious complications and for successful management.


Subject(s)
Adult , Glucosephosphate Dehydrogenase Deficiency/complications , Hepatitis B/complications , Humans , Hyperbilirubinemia/complications , Male , Thailand/epidemiology
19.
Arq. bras. cardiol ; 54(6): 393-395, jun. 1990. ilus
Article in Portuguese | LILACS | ID: lil-86727

ABSTRACT

Mulher de 52 anos foi submetida a substituiçäo valvar mitral. O ato operatório transcorreu sem anormalidades. Desde o primeiro dia pós-operatório (po), apresentou icterícia de intensidade progressiva as custas de bilirrubina direta. A semiologia abdominal foi normal, e näo havia sinais de infecçäo ou instabilidade hemodinámica. A taxa de bilirrubina direta foi 6 mg/dl no segundo dia po, 20,4 mg/dl no sexto e 32 mg/dl no décimo. A taxa de gamaglutamil transferase foi 600 U/L (normal até 18 U/L) e a de desidrogenase lática 396 U/L (normal até 240 U/L) no sétimo dia po. A taxa de fosfatase alcalina foi 1880 U/L (normal até 170 U/L), enquanto que a de transminase glutâmico-oxalacética foi 60 U/L (normal até 15 U/L) e transaminase glutâmico-pirúvica 66 U/L (normal até 17 U/L) no décimo dia po. A ultrassonografia do abdome näo revelou dilataçäo das vias biliares intra ou extra-hepáticas. A paciente morreu depois depois de uma biopsia hepática percutânea. A icterícia foi atribuída a sínddrome colestática, freqüente no período po de cirurgia cardíaca, na qual há distúrbio transitório da funçäo excretora do hepatócito de etiologia multifatorial


A 52-year old woman was submitted to mitral valve replacement. The operation proceeded without complications. Jaundice had been noted since the first postoperative (po) day and increased progressively due to conjugated bilirubin. Abdominal examination was normal and no signs of infection or circulatory failure were noted. Conjugated bilirubin levels increased from 6 mg/dl on the second po day to 20,4 mg/ dl on the sixth po day and to 32 mg/dl on the tenth po day. Gamaglutamyl transferase levels were 600 U/L (normal up to 18 U/L) and lactate dehydrogenase levels were 396 U/L (normal) up to 240 U/L) on the seventh po day. Alkaline phosphatase levels were 1880 U/L (normal up to 170 U/L) whereas glutamic oxalacetic transaminase levels were 60 U/ L (normal up to 15 U/L) and glutamic pyruvic transaminase levels were 66 U/L (normal up to 17 U/L) on the tenth po day. Abdominal ultrasonography did not disclose dilatation of intra and extra-hepatic biliary system. The patient died after a percutaneous hepatic biopsy procedure. The jaundice was atributted to a cholestatic syndrome after cardiac surgery and cardiopulmonary bypass, due to an impairment of the excretory function of the hepatocyte.


Subject(s)
Humans , Female , Middle Aged , Cholestasis/etiology , Hyperbilirubinemia/complications , Postoperative Complications , Mitral Valve Insufficiency/surgery , Cholestasis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL